BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Manufacturing

  Drugmakers Hail Early Wins in AI-Driven Transformation of Manufacturing

  Companies have claimed improvements to yield, batch consistency and output while acknowledging the risks and challenges created by the technology.

  August 26, 2025

   · 

  5 min read

   · 

  Nick Paul Taylor
• 

  Vaccines

  Trump, Kennedy Could Ban COVID-19 Vaccine ‘Within Months’: Report

  The White House has denied reports that the government could soon ban COVID-19 vaccines, noting that in the absence of an official announcement, “any discussion about HHS policy should be dismissed as baseless speculation.”

  August 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Rare diseases

  Argenx Eyes ‘Broadest Label’ for Vyvgart in Myasthenia Gravis After Positive Phase III Data

  Based on new data, argenx expects to file for the expansion of Vyvgart’s label into patients with generalized myasthenia gravis who are negative for antibodies against the AChR marker—an indication William Blair analysts called the broadest option in this disease space.

  August 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  COVID-19

  CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup

  The MIT professor of management, who already sits on the CDC’s revamped immunization advisory committee, is a known skeptic of vaccines, particularly mRNA technology.

  August 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Podcast

  Oral Weight-Loss Race Heats Up as New Data From Lilly, Viking Reset Expectations

  Closely watched data from Eli Lilly and Viking Therapeutics this month have reignited the discussion around oral weight-loss drugs—and their ultimate place within the anti-obesity medication market.

  August 26, 2025

   · 

  1 min read

   · 

  Jef Akst
• 

  Layoffs

  Appia, Former Kite Cell Therapy Collaborator, Shuts Down

  Appia Bio’s shutdown continues an unfortunate trend this year that has seen biotech closures nearly every month.

  August 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Obesity

  Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron

  While Truist Securities analysts said the results from the ATTAIN-2 trial leave “room for competition,” they also pointed to a manufacturing advantage that could unlock a “double-digit billion dollar opportunity” for Eli Lilly.

  August 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

  August 26, 2025

   · 

  6 min read
• Press Releases

  Insulet Elevates Eric Benjamin to Chief Operating Officer

  August 26, 2025

   · 

  3 min read
• Press Releases

  Vir Biotechnology to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

  August 26, 2025

   · 

  1 min read